Table 5.
Effect of ANC characteristics of respondent on IPTp-SP uptake of ≥3 doses
| Characteristics | IPTp-SP uptake | COR (95% CI) | p value | AOR (95% CI) | p value | |
|---|---|---|---|---|---|---|
| <3 doses n (%) | ≥3 doses n (%) | |||||
| Gestational age at first ANC visit | ||||||
| First trimester | 7 (6.67) | 98 (93.33) | Ref | Ref | ||
| Second trimester | 12 (9.52) | 114 (90.48) | 0.68 (0.26–1.79) | 0.434 | 0.74 (0.22–2.46) | 0.630 |
| Third trimester | 13 (54.17) | 11 (45.83) | 0.06 (0.02–0.18) | <0.001 | 2.8 (0.31–24.55) | 0.352 |
| Number of visits | ||||||
| <4 | 14 (48.28) | 15 (51.72) | Ref | Ref | ||
| ≥4 | 18 (7.96) | 208 (92.04) | 10.76 (4.5–25.82) | <0.001 | 4.57 (1.15–18.16) | 0.031 |
| Gestational age at first dose of SP | ||||||
| Second trimester | 11 (5.05) | 207 (94.95) | Ref | Ref | ||
| Third trimester | 18 (52.94 | 16 (47.06) | 0.05 (0.02–0.12) | <0.001 | 0.04 (0.01–0.16) | <0.001 |
COR crude odds ratio, AOR adjusted odds ratio, 95% CI 95% confidence interval, Ref reference
Significant p values are presented in italics